GlaxoSmithKline: Rhinitis, Allergic trials

The registry lists 34 Rhinitis, Allergic studies with GlaxoSmithKline as lead sponsor. 0 are open to participants now and 15 have results posted.

Phase 1 5Phase 2 8Phase 3 9Phase 4 8No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Follow-up Study to Investigate the Effect of GSK2245035 on Nasal Allergic Reactivity in Subjects Completing Treatment in Study TL7116958CompletedNCT02446613Phase 2Results posted
• A Study to Compare the Efficacy and Safety of Fluticasone Furoate Nasal Sprays (FFNS) 55 Microgram (mcg) and 110 mcg in Chinese Pediatric Subjects With Allergic Rhinitis (AR)CompletedNCT02424539Phase 4Results posted
• Patient Preference Study of Fluticasone Furoate and Mometasone Furoate Nasal SpraysCompletedNCT02397915Phase 4Results posted
• A Proof of Concept Study to Assess Effect of Fluticasone Furoate (FF)/Levocabastine Fixed Dose Combination (FDC) Compared With Levocabastine and FF Alone in Subjects With Allergic Rhinitis (AR)CompletedNCT01957202Phase 2Results posted
• A Study to Assess Intranasal Repeat Dose Effect of Levocabastine in the Subjects With Allergic RhinitisCompletedNCT01949051Phase 2Results posted
• Assessment of Fluticasone Propionate on Ocular Allergy SymptomsCompletedNCT01817790Phase 3Results posted
• Safety Study of Levocetirizine Oral Solution for Japanese PediatricsCompletedNCT01563081Phase 3Results posted
• A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Nasal Spray for 2 Weeks in Chinese Adult and Adolescent Subjects With Allergic RhinitisCompletedNCT01231464Phase 3Results posted
• A Randomised, Double Blind, Placebo Controlled, 4 Period, Incomplete Block, Crossover Study Assessing the Dose-response Curve of Fluticasone Propionate in an Antigen Challenge ChamberCompletedNCT00848965Phase 4Results posted
• Phase 4 Fluticasone Furoate Nasal Spray (VERAMYST) Long Term Pediatric Growth Study.CompletedNCT00570492Phase 4Results posted
• Fluticasone Furoate Nasal Spray Versus Oral FexofenadineCompletedNCT00502775Phase 4Results posted
• Fluticasone Furoate Nasal Spray Versus Oral FexofenadineCompletedNCT00435461Phase 4Results posted
• Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q)CompletedNCT00346775Phase 3Results posted
• Study Of Allergic Rhinitis In Patients Who Also Have AsthmaCompletedNCT00296491Phase 4Results posted
• Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)CompletedNCT00289198Phase 3Results posted
• Post Marketing Surveillance for Contac Bien Z in JapanCompletedNCT02020902
• A Relative Bioavailability Study of Fluticasone Furoate and LevocabastineCompletedNCT01962467Phase 1
• To Investigate the Safety, Pharmacodynamics and Effect on Allergic Reactivity of the Toll-like Receptor 7 (TLR7) Agonist GSK2245035 in Subjects With Respiratory AllergiesCompletedNCT01788813Phase 2
• A Study to Investigate the Safety and Pharmacodynamics of Repeat Intranasal Administration of the TLR7 Agonist GSK2245035 in Subjects With Respiratory AllergiesCompletedNCT01607372Phase 2
• An Investigation of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2245035 in Healthy Volunteers and Allergic Rhinitics.CompletedNCT01480271Phase 1
• Prospective Observational Study of Concomitant Allergic Rhinitis Treatment Patterns Among Patients Starting on Fluticasone Furoate Nasal Spray in a Retail Pharmacy SettingTerminatedNCT01337323
• A Comparison of Patients on AVAMYS ® Versus NASONEX (A Trade Mark of Schering Corporation) and FLIXONASE ® on Key Health Outcome MeasuresCompletedNCT01199757
• Regulatory AVAMYS Nasal Spray PMSCompletedNCT01001130
• Allergen Challenge Chamber Study With Single Dose Oral GSK835726 Compared With PlaceboCompletedNCT00851344Phase 2
• Allergen Challenge Chamber Study With Single Dose Intranasal GSK1004723 Compared With PlaceboCompletedNCT00824356Phase 2
• Single and Repeat Dose First Time in Human Study for an Intranasal H1/H3 Dual Antagonist in Healthy Male SubjectsCompletedNCT00694993Phase 1
• A Phase II Study Evaluating Intranasal GSK256066 and Azelastine Hydrochloride in Subjects With Seasonal Allergic RhinitisCompletedNCT00612118Phase 2
• Investigation Of a New Oral Anti-Histamine in Healthy Male SubjectsCompletedNCT00605852Phase 1
• Study of GW685698X In Patients With Seasonal Allergic RhinitisCompletedNCT00363740Phase 3
• Exploration Of Key Targets And Biomarkers Involved In An Allergic Response In Subjects With Allergic Rhinitis (Hay Fever)CompletedNCT00348361Phase 1
• Study Of Patients With Allergic Rhinitis And AsthmaCompletedNCT00296530Phase 4
• Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)CompletedNCT00197262Phase 3
• Study In Adults And Adolescents With Seasonal Allergic RhinitisCompletedNCT00115622Phase 3
• A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR).CompletedNCT00103454Phase 3